In Vitro Antifungal Activity of Selected Essential Oils against Drug-Resistant Clinical Aspergillus spp. Strains
Molecules · 2023
DOI: 10.3390/molecules28217259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Valeria Allizond und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department Public Health and Pediatrics, Microbiology Division, University of Torino, 10126 Turin, Italy. Hauptthemen laut MEDLINE: Antifungal Agents, Oils, Volatile. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Treatment options for aspergillosis include amphotericin B (AMB) and azole compounds, such as itraconazole (ITZ). However, serious side effects related to these antifungal agents are increasingly evident, and resistance continues to increase. Currently, a new trend in drug discovery to overcome this problem is represented by natural products from plants, or their extracts. Particularly, there is a great interest in essential oils (EOs) recognized for their antimicrobial role towards bacteria, fungi and viruses.
Methods
In this study, we evaluated the antifungal activity of eleven commercial EOs—clove, eucalyptus, geranium, hybrid lavender, lavender, lemon, lemongrass, neroli, oregano, tea tree and red red thyme—in comparison with AMB and ITZ against Aspergillus flavus, A. fumigatus and A. niger clinical isolates. Antifungal activity was determined by broth microdilution method, agar diffusion technique, fungistatic and fungicidal activities and vapor contact assay.
Results
Gas chromatography–mass spectrometry analysis displayed two groups of distinct biosynthetical origin: monoterpenes dominated the chemical composition of the most oils. Only two aromatic compounds (eugenol 78.91% and eugenyl acetate 11.64%) have been identified as major components in clove EO. Lemongrass EO exhibits the strongest antimicrobial activity with a minimum inhibitory concentration of 0.56 mg/mL and a minimum fungicidal concentration of 2.25–4.5 mg/mL against Aspergillus spp. strains. Clove and geranium EOs were fairly effective in inhibiting Aspergillus spp. growth.
Conclusions
These results demonstrate the antimicrobial potential of some EOs and support the research of new alternatives or complementary therapies based on EOs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Public Health and Pediatrics, Microbiology Division, University of Torino, 10126 Turin, Italy.
ORCID-Profile: Valeria Allizond, Lorenza Cavallo, Janira Roana, Narcisa Mandras, Vivian Tullio, Giuliana Banche
Zitieren
APA
Allizond, V., Cavallo, L., Roana, J., Mandras, N., Cuffini, A. M., Tullio, V., & Banche, G. (2023). In Vitro Antifungal Activity of Selected Essential Oils against Drug-Resistant Clinical Aspergillus spp. Strains. Molecules. https://doi.org/10.3390/molecules28217259
Vancouver
Allizond V, Cavallo L, Roana J, Mandras N, Cuffini AM, Tullio V, et al. In Vitro Antifungal Activity of Selected Essential Oils against Drug-Resistant Clinical Aspergillus spp. Strains. Molecules. 2023. doi:10.3390/molecules28217259
BibTeX
@article{Allizond2023,
author = {Allizond, Valeria and Cavallo, Lorenza and Roana, Janira and Mandras, Narcisa and Cuffini, Anna Maria and Tullio, Vivian and Banche, Giuliana},
title = {In Vitro Antifungal Activity of Selected Essential Oils against Drug-Resistant Clinical Aspergillus spp. Strains},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28217259}
}
EUVIMED